Mehmet Tahir Hüsunet

Mehmet Tahir Hüsunet

Auto-generated profile, based on publicly available information

Mehmet Tahir Hüsunet

Gaziantep Islam Science and Technology University

Research Focus & Metrics

Academic Career Length

10Years (2017-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
27 January 2021 in Drug and Chemical Toxicology
Verified
Journal Article
Closed access
MHMehmet Tahir Husunet
Mehmet Tahir Husunet
RMRima Çelik Mısırlı
Rima Çelik Mısırlı
Erman Salih ISTIFLIErman Salih ISTIFLI
Erman Salih ISTIFLI
HIHasan Basri Ila
Hasan Basri Ila
Patent Blue V (PBV) is a water-soluble synthetic dyestuff that is used as a coloring agent in the food industry and for medical imaging in health monitoring. The aim of this study was to investigate the in vitro clastogenic, aneugenic and cytotoxic effects of PBV in human peripheral lymphocytes using micronucleus assay, comet assay, as well as plasmid DNA interaction and bacterial AMES tests. In addition to in vitro tests, the affinity of PBV against DNA was determined by molecular docking analysis in silico. PBV produced significant MN formation only at high doses and longer treatment time, however, it did not significantly affect the nuclear division index (NDI). Furthermore, PBV was unable to cause DNA single-strand breaks and significant oxidative damage on the pBR322 plasmid DNA and it didn’t reverse the harmful effects caused by the clastogenic treatment of UV + H2O2 on plasmid DNA. In the Ames test, no significant increase was detected in the number of revertant colonies of mutant strains, TA98 and TA100, following PBV treatment. No significant molecular interaction between B-DNA and PBV occured in molecular docking simulations. In conclusion, PBV had no significant genotoxic and cytotoxic effects in this study. However, considering that the information intensity related to the genotoxic effects of PBV in the literature is still insufficient, reports of further studies with different genotoxicity endpoints will be needed to elucidate the exact genotoxic feature.

28 October 2020 in Journal of Biomolecular Structure and Dynamics
Verified
Journal Article
Closed access
Erman Salih ISTIFLIErman Salih ISTIFLI
Erman Salih ISTIFLI
PNPaulo Augusto Netz
Paulo Augusto Netz
ATArzuhan Sihoglu Tepe
Arzuhan Sihoglu Tepe
MHMehmet Tahir Husunet
Mehmet Tahir Husunet
CSCengiz Sarikurkcu
Cengiz Sarikurkcu
BTBektas Tepe
Bektas Tepe
Coronavirus Disease 2019 (COVID-19) has infected more than thirty five million people worldwide and caused nearly 1 million deaths as of October 2020. The microorganism causing COVID-19 was named as Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2 or 2019-nCoV). The aim of this study was to investigate the interactions of twenty-three phytochemicals belonging to different flavonoid subgroups with the receptor binding domain (RBD) of the spike glycoprotein of 2019-nCoV, and cellular proteases [transmembrane serine protease 2 (TMPRSS2), cathepsin B and L (CatB/L)]. The compounds interacted more strongly with CatB and CatL than with the other proteins. Van der Waals and hydrogen bonds played an important role in the receptor-ligand interactions. As a result of RBCI (relative binding capacity index) analysis conducted to rank flavonoids in terms of their interactions with the target proteins, (-)-epicatechin gallate interacted strongly with all the proteins studied. The results obtained from molecular dynamics and molecular mechanics Poisson-Boltzmann surface area (MM/PBSA) methods also supported this data. According to Lipinski's rule of five, (-)-epicatechin gallate showed drug-likeness properties. Although this molecule is not capable of crossing the blood-brain barrier (BBB), it was concluded that (-)-epicatechin gallate can be evaluated as a candidate molecule in drug development studies against 2019-nCoV since it was not the substrate of P-gp (P-glycoprotein), did not inhibit any of the cytochrome Ps, and did not show AMES toxicity or hepatotoxicity on eukaryotic cells.

12 March 2025 in European Journal of Therapeutics
Verified
Journal Article
Open access
PDF file
BBBatuhan Bilgin
Batuhan Bilgin
MHMehmet Tahir Husunet
Mehmet Tahir Husunet
Objective: Gadobutrol is a macrocyclic gadolinium-based contrast agent (GBCA) used in magnetic resonance imaging (MRI). Although it is also used in the imaging of malignant tumors, its effect on SH-SY5Y neuroblastoma cells remains unclear. The aim of this study was to investigate the effects of gadobutol on cytotoxicity and genotoxicity in SH-SY5Y neuroblastoma cells. Methods: After incubation of neuroblastoma cells with gadobutrol (0.1 mM, 1 mM, 10 mM, and 100 mM), cell viability was assessed by 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyl-2H-tetrazolium bromide (MTT) assay. After determining the IC 50 value of gadobutrol, the genotoxicity effect of gadobutrol (1.75 mM, 3.50 mM, and 7 mM) on neuroblastoma cells was examined by Comet assay. Results: Gadobutrol (0.1 mM, 1 mM, 10 mM, and 100 mM) statistically significantly decreased cell viability in SH-SY5Y neuroblastoma cells (p < 0.0001, p < 0.0001, p < 0.0001 and p < 0.0001, respectively). Gadobutrol (1.75 mM, 3.50 mM, and 7 mM) caused an increase in genotoxicity in neuroblastoma cells. However, gadobutrol (3.50 mM) and gadobutrol (7 mM) statistically significantly increased genotoxicity in neuroblastoma cells (p < 0.05 and p < 0.01, respectively). Conclusion: The results of this in vitro study show that gadobutrol used as a contrast agent in MRI increases both cytotoxicity and genotoxicity in SH-SY5Y neuroblastoma cells. The cytogenotoxic effect of gadobutrol in SH-SY5Y neuroblastoma cells may point to it as a promising new strategy for the treatment of neuroblastoma.

8 February 2023 in Drug and Chemical Toxicology
Verified
Journal Article
Closed access
IKİbrahim Halil Kenger
İbrahim Halil Kenger
HYHAMIT YILDIZ
HAMIT YILDIZ
MHMehmet Tahir Hüsunet
Mehmet Tahir Hüsunet
LDLale Dönbak
Lale Dönbak
AKAhmet Kayraldız
Ahmet Kayraldız
Vigabatrin (VGB) is a gammaaminobutyric acid-ergic (GABA-ergic) antiepileptic drug (AED) and is one of 2 approved drugs available to treat infantile spasms (IS). The aim of this study is to elucidate conflicting data on the toxic effects of VGB and to obtain detailed information about its possible cytogenotoxic effects in human lymphocytes. For this purpose, in vitro Chromosomal Aberration (CA), Sister Chromatid Exchange (SCE), Micronucleus (MN) tests, and Comet Assay were performed to determine possible genotoxic and cytotoxic effects of VGB. In addition, the binding energy level of VGB to DNA was determined in silico by molecular docking. The highest concentration (80 μg/ml) of VGB increased the SCE, CA, MN and micronucleated binuclear cell (BNMN) frequency significantly compared to the control after 24 and 48 hours of treatment. In the tail density and tail length parameters, the dose-dependent increase was found to be statistically significant compared to the control. At the 40 and 80 μg/ml concentrations of VGB for 48 hours caused a statistically significant increase in both CA/Cell and AC percentages, while MI and NDI decreased only significantly at the highest concentration (80 µg/ml) causing. In the Comet Assay head density, tail density and tail length parameters, the dose-dependent increase was found to be statistically significant compared to the control. Also, the in silico molecular docking analysis showed that VGB interacts with B-DNA close to the threshold binding energy. The lowest negative free binding energy (ΔG binding) was found as −5.13 kcal/mol. In conclusion, all results are evaluated together, it has been determined that VGB has cytogenotoxic effects in vitro and binds to DNA in silico with significant free binding energy.

12 February 2024 in Experimental and Applied Medical Science
Verified
Journal Article
Open access
PDF file
SASultan Akar
Sultan Akar
TÇTuğba Çırak
Tuğba Çırak
MHMehmet Tahir Hüsunet
Mehmet Tahir Hüsunet
ITIpek Turkdonmez
Ipek Turkdonmez
IKİbRahim Halil Kenger
İbRahim Halil Kenger
AKAhmet Kayraldız
Ahmet Kayraldız
In recent years, studies that investigate the effects of chemical compounds on organisms have increased in direct proportion to their widespread use. In this study, four different bidentate imine ligands and bidentate imine ligands+Cu(II) complexes were synthesized from the bioactive synthetic diarylmethylamine compound. After the ligands and metal complexes obtained were purified using chromatographic and analytical methods, their mutagenic effects were investigated with the Ames/Salmonella test system. In addition, interactions of four different Cu(II) complexes with B-DNA were evaluated with molecular docking analysis. Accordingly, the results indicated a significant increase in the colonies formed in the presence (+S9) and absence (-S9) of the metabolic activation system, meaning a mutagenic effect against strain TA98 and TA100 strains in general.

24 October 2022 in Drug and Chemical Toxicology
Verified
Journal Article
Closed access
YOYasemin Eldemir Okay
Yasemin Eldemir Okay
IKİbRahim Halil Kenger
İbRahim Halil Kenger
HYHAMIT YILDIZ
HAMIT YILDIZ
MHMehmet Tahir Hüsunet
Mehmet Tahir Hüsunet
LDLale Dönbak
Lale Dönbak
AKAhmet Kayraldiz
Ahmet Kayraldiz
Two different drug groups, typical (classic) and atypical (new), are used in the treatment of schizophrenia. Aripiprazole, an atypical antipsychotic chemical, is the active ingredient of the drug Abilify. This study was conducted to determine the possible genotoxic effect of aripiprazole. For this purpose, four different doses of aripiprazole (5; 10; 20, and 40 µg/mL) were examined with Chromosome Abnormality (CA), Sister Chromatid Exchange (SCE), Micronucleus (MN) tests. Based on these tests, Proliferation Index (PI), Percent Abnormal Cells (AC), Mitotic Index (MI), Micronuclear Binuclear Cell (MNBN), and Nuclear Division Index (NDI) levels were determined in human peripheral lymphocytes treated for 24 and 48 hours. Also, to determine possible binding sites of Aripiprazole on B-DNA molecular docking analysis was performed using AutoDock 4.0 (B-DNA dodecamer, PDB code: 1BNA). Aripiprazole binds to B-DNA with a very significant free binding energy (–11.88 Kcal/mol). According to our study, aripiprazole did not significantly change SCE, CA, AC percentage, MN frequencies when compared with control. According to these results, aripiprazole does not have a genotoxic effect. At the same time, no significant change was observed in the PI, MI, and NDI frequencies when compared with the control. In line with these results, it was observed that the use of aripiprazole in the treatment of schizophrenia did not pose any acute genotoxic and cytotoxic risk.